Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding

被引:89
作者
Crown, Susan E.
Yu, Yonghao
Sweeney, Matthew D.
Leary, Julie A. [1 ]
Handel, Tracy M.
机构
[1] Univ Calif Davis, Dept Chem, Genome Ctr, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Mol Cell Biol, Genome Ctr, Davis, CA 95616 USA
[3] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[5] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M601518200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Despite the wide range of sequence diversity among chemokines, their tertiary structures are remarkably similar. Furthermore, many chemokines form dimers or higher order oligomers, but all characterized oligomeric structures are based primarily on two dimerization motifs represented by CC-chemokine or CXC-chemokine dimer interfaces. These observations raise the possibility that some chemokines could form unique hetero-oligomers using the same oligomerization motifs. Such interactions could modulate the overall signaling response of the receptors, thereby providing a general mechanism for regulating chemokine function. For some chemokines, homo-oligomerization has also been shown to be coupled to glycosaminoglycan (GAG)-binding. However, the effect of GAG binding on chemokine hetero-oligomerization has not yet been demonstrated. In this report, we characterized the heterodimerization of the CCR2 ligands MCP-1 (CCL2), MCP-2 (CCL8), MCP-3 (CCL7), MCP-4 (CCL13), and eotaxin (CCL11), as well as the effects of GAG binding, using electrospray ionization Fourier transform ion cyclotron resonance (ESI-FTICR) mass spectrometry. Strong heterodimerization was observed between CCL2 and CCL8 at the expense of homodimer formation. Using NMR, we showed that the heterodimer is predominant in solution and forms a specific CC chemokine-like dimer. By contrast, only moderate heterodimer formation was observed between CCL2(.)CCL13, CCL2(.)CCL11 and CCL8(.)CCL13, and no heterodimerization was observed when any other CCR2 ligand was added to CCL7. To investigate the effect of a highly sulfated GAG on the formation of heterodimers, each chemokine pair was mixed with the heparin pentasaccharide, Arixtra, and assayed by ESI-FTICR mass spectrometry. Although no abundant ions corresponding to the ternary complex, CCL8(.)CCL11(.)Arixtra, were observed upon addition of Arixtra. Heterodimerization between CCL2 and CCL11 was also enhanced in the presence of Arixtra. In summary, these results indicate that some CCR2 ligands can form stable heterodimers in preference to homodimers and that these interactions, like those of homo-oligomers, can be influenced by some GAGs.
引用
收藏
页码:25438 / 25446
页数:9
相关论文
共 56 条
[1]
Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[2]
Involvement of β-chemokines in the development of inflammatory demyelination [J].
Banisor, Ileana ;
Leist, Thomas P. ;
Kalman, Bernadette .
JOURNAL OF NEUROINFLAMMATION, 2005, 2 (1)
[3]
Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors [J].
Blaszczyk, J ;
Van Coillie, E ;
Proost, P ;
Van Damme, J ;
Opdenakker, G ;
Bujacz, GD ;
Wang, JM ;
Ji, XH .
BIOCHEMISTRY, 2000, 39 (46) :14075-14081
[4]
MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS [J].
CHARO, IF ;
MYERS, SJ ;
HERMAN, A ;
FRANCI, C ;
CONNOLLY, AJ ;
COUGHLIN, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2752-2756
[5]
COMBADIERE C, 1995, J BIOL CHEM, V270, P29671
[6]
Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation [J].
Crump, MP ;
Rajarathnam, K ;
Kim, KS ;
Clark-Lewis, I ;
Sykes, BD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22471-22479
[7]
Multiple chemotactic factors: fine control or redundancy? [J].
Devalaraja, MN ;
Richmond, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (04) :151-156
[8]
Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds EL-8: novel mechanisms for modulation of hematopoiesis [J].
Dudek, AZ ;
Nesmelova, I ;
Mayo, K ;
Verfaillie, CM ;
Pitchford, S ;
Slungaard, A .
BLOOD, 2003, 101 (12) :4687-4694
[9]
Structure junction, and inhibition of chemokines [J].
Fernandez, EJ ;
Lolis, E .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :469-499
[10]
Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-γ [J].
Fulkerson, PC ;
Zimmermann, N ;
Hassman, LM ;
Finkelman, FD ;
Rothenberg, ME .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7565-7574